CONCLUSIONS: Our trifecta is the first standardized and reproducible system specifically designed to provide a comprehensive summary of global results after RARC with ON. Although external validation studies are required, this novel tool may optimize outcomes reporting and facilitate comparisons between various surgical technique.
INTRODUCTION AND OBJECTIVES: Poor access to local urology care is associated with high urologic cancer mortality rates (MR) . The use of remote video visits (a form of telemedicine) has been proposed as a strategy to decrease geographic disparities in urologic cancer MR. However, remote video visits require participants to use high-speed internet that may not be available to them. We therefore identified US counties with high urologic cancer MR, poor access to local urology care and adequate internet access to inform the strategic deployment of telemedicine.
METHODS: US counties with age-adjusted MR ! 90th percentile for bladder, kidney, prostate, or testis cancer (deaths per 100,000 in 2014) were identified via a small-area estimation model that utilized death records from the National Center for Health Statistics. Counties were further delineated based on internet access rates (IAR) and urologist presence. Counties were determined to have adequate IAR if ! 50% of the population had access to residential fixed broadband internet at speeds ! 25 Mbps download/3 Mbps upload. IAR were obtained from 2016 Federal Communications Commission filings. Urologist presence was obtained from 2015 US Health Resources and Services Administration data. State level information regarding telemedicine coverage, reimbursement, practice standards and licensure was obtained from the American Telemedicine Association and integrated into our analysis.
RESULTS: 397 counties have high MR in at least one urologic cancer, no access to a local urologist, and adequate IAR (Fig 1) . 23 of these counties are located in states with favorable telemedicine regulations. 99 counties had adequate IAR, no access to a local urologist, and a high MR in at least two of four urologic cancers. 5 of those counties are in states with favorable telemedicine regulations.
CONCLUSIONS: There are 940 counties in the US with high MR from at least one urologic cancer. Nearly 400 of these counties (42%) lack a local urologist, but have the internet infrastructure to test the benefits of remote video visits immediately. Urologists interested in using telemedicine to address geographic disparities in cancer mortality should consider targeting the counties identified in our analysis for future interventions.
Source of Funding: American Urological Association Data Grant
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A NOVEL APPROACH TO IDENTIFY DISPARITIES IN ACCESS TO UROLOGIC CARE BASED ON DRIVING TIME Brock O'Neil*, Ross Anderson, Christopher Martin, Claire Leiser, Heidi Hanson, Salt Lake City, UT INTRODUCTION AND OBJECTIVES: Rural patients regularly travel substantial distances in order to obtain medical care. Several studies have identified an association between longer travel distance and worse outcomes. Historically county level or zip code-based data has been used for crude estimates of access to care. Using provider location and US Census Data we sought to characterize deserts of urologic care using driving time.
METHODS: Using the National Provider Identifier we identified and geocoded the location of practicing urologists who billed Medicare in 2015. We developed drive-time based service areas for these providers using population centroids provided by Esri, a geographic information system supplier. Next, we determined the density of urologists (i.e. number of urologists per population) within each Health Referral Region. By using both drive time and urologist density, we mapped areas of low access to urologic care. RESULTS: We found that over 97% of the population lives within a 60 minute drive to at least one urologist (Table 1 ). The south central AUA section demonstrated the longest average drive times. When considering the density of providers together with populations that live within an hour, there are large sections of the US that demonstrate lack of timely access to any urologists (Figure 1) . This is most pronounced in the western and central US but with pockets throughout the south and east. There is also substantial heterogeneity in terms of provider density with many areas throughout the country where populations have timely access to few urologists providing care.
CONCLUSIONS: Drive time combined with urologist density is a novel approach to determine access to urologic care. Substantial variation exists for patients across the country with much of the geographic US characterized by poor access to urologic care with few providers providing care for large populations. Future work will need to establish whether such disparities in access to care translate to disparities in urologic outcomes. METHODS: We analyzed inpatient and ambulatory urologic surgeries for patients !18 years of age in the 2010 -2014 and North Carolina (NC) Ambulatory/Inpatient Surgery Databases. These databases capture 100% of ambulatory and inpatient procedures in their respective states. The primary outcome of this study was ERT,
